Targeted magnetic delivery and tracking of cells using a magnetic resonance imaging system.

The success of cell therapies depends on the ability to deliver the cells to the site of injury. Targeted magnetic cell delivery is an emergent technique for localised cell transplantation therapy. The use of permanent magnets limits such a treatment to organs close to the body surface or an implanted magnetic source. A possible alternative method for magnetic cell delivery is magnetic resonance targeting (MRT), which uses magnetic field gradients inherent to all magnetic resonance imaging system, to steer ferromagnetic particles to their target region. In this study we have assessed the feasibility of such an approach for cell targeting, using a range of flow rates and different super paramagnetic iron oxide particles in a vascular bifurcation phantom. Using MRT we have demonstrated that 75% of labelled cells could be guided within the vascular bifurcation. Furthermore we have demonstrated the ability to image the labelled cells before and after magnetic targeting, which may enable interactive manipulation and assessment of the distribution of cellular therapy. This is the first demonstration of cellular MRT and these initial findings support the potential value of MRT for improved targeting of intravascular cell therapies.

[1]  A. Quyyumi,et al.  Cell Therapy in Peripheral Arterial Disease , 2008, Angiology.

[2]  Jeroen J. Bax,et al.  Effect of intramyocardial bone marrow cell injection on left ventricular dyssynchrony and global strain , 2008, Heart.

[3]  Alan P Koretsky,et al.  Highly efficient endosomal labeling of progenitor and stem cells with large magnetic particles allows magnetic resonance imaging of single cells. , 2003, Blood.

[4]  K. Shimada,et al.  Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial , 2002, The Lancet.

[5]  C. Borlongan.  Cell Therapy for Stroke: Remaining Issues to Address Before Embarking on Clinical Trials , 2009, Stroke.

[6]  S. Martel,et al.  Automatic navigation of an untethered device in the artery of a living animal using a conventional clinical magnetic resonance imaging system , 2007 .

[7]  H. Drexler,et al.  Clinical applications of stem cells for the heart. , 2005, Circulation research.

[8]  R. Cate,et al.  Autologous stem cell transplantation in children with severe progressive systemic or polyarticular juvenile idiopathic arthritis: long-term follow-up of a prospective clinical trial. , 2007, Arthritis and rheumatism.

[9]  Q. Pankhurst,et al.  Applications of magnetic nanoparticles in biomedicine , 2003 .

[10]  J. Snowden,et al.  Clinical stem cell therapies for severe autoimmune diseases , 2009, Transfusion medicine.

[11]  C Alexiou,et al.  Clinical applications of magnetic drug targeting. , 2001, The Journal of surgical research.

[12]  Richard C Darton,et al.  Manipulation and tracking of superparamagnetic nanoparticles using MRI. , 2008, Nanotechnology.

[13]  Bobbi K Lewis,et al.  In vivo trafficking and targeted delivery of magnetically labeled stem cells. , 2004, Human gene therapy.

[14]  Alan P Koretsky,et al.  Antibody-mediated cell labeling of peripheral T cells with micron-sized iron oxide particles (MPIOs) allows single cell detection by MRI. , 2007, Contrast media & molecular imaging.

[15]  K. Remes.  Cell therapy , 2002, Journal of the Neurological Sciences.

[16]  Florence Gazeau,et al.  Universal cell labelling with anionic magnetic nanoparticles. , 2008, Biomaterials.

[17]  Christoph Alexiou,et al.  Magnetic nanoparticles as bimodal tools in magnetically induced labelling and magnetic heating of tumour cells: an in vitro study , 2007 .

[18]  S. Martel,et al.  Magnetic nanoparticles encapsulated into biodegradable microparticles steered with an upgraded magnetic resonance imaging system for tumor chemoembolization. , 2009, Biomaterials.

[19]  N. Adachi,et al.  Accumulation of magnetically labeled rat mesenchymal stem cells using an external magnetic force, and their potential for bone regeneration. , 2008, Journal of biomedical materials research. Part A.

[20]  M. Galiñanes,et al.  Autotransplantation of Unmanipulated Bone Marrow into Scarred Myocardium is Safe and Enhances Cardiac Function in Humans , 2004, Cell transplantation.

[21]  Armin D. Ebner,et al.  Implant assisted-magnetic drug targeting : Comparison of in vitro experiments with theory , 2008 .

[22]  Sylvain Martel,et al.  Real-Time MRI-Based Control of a Ferromagnetic Core for Endovascular Navigation , 2008, IEEE Transactions on Biomedical Engineering.

[23]  P. Wielopolski,et al.  Effects of iron oxide incorporation for long term cell tracking on MSC differentiation in vitro and in vivo. , 2008, Biochemical and biophysical research communications.

[24]  H. Zhang,et al.  Mesenchymal stem cells and cardiac repair , 2008, Journal of cellular and molecular medicine.

[25]  B. Rosen,et al.  Microscopic susceptibility variation and transverse relaxation: Theory and experiment , 1994, Magnetic resonance in medicine.

[26]  S. Martel,et al.  Aggregation of magnetic microparticles in the context of targeted therapies actuated by a magnetic resonance imaging system , 2009 .

[27]  C. Yerebakan,et al.  Autologous bone marrow stem cell therapy for the ischemic myocardium during coronary artery bypass grafting , 2008, Minimally invasive therapy & allied technologies : MITAT : official journal of the Society for Minimally Invasive Therapy.

[28]  Thomas Kelly,et al.  In vivo magnetic enrichment and multiplex photoacoustic detection of circulating tumour cells. , 2009, Nature nanotechnology.

[29]  Bernd Hertenstein,et al.  Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial , 2004, The Lancet.

[30]  Gary Friedman,et al.  High field gradient targeting of magnetic nanoparticle-loaded endothelial cells to the surfaces of steel stents , 2008, Proceedings of the National Academy of Sciences.

[31]  Pauliina Lehtolainen,et al.  Magnetic tagging increases delivery of circulating progenitors in vascular injury. , 2009, JACC. Cardiovascular interventions.

[32]  Ross Ihaka,et al.  Gentleman R: R: A language for data analysis and graphics , 1996 .

[33]  M. Kaufman,et al.  Establishment in culture of pluripotential cells from mouse embryos , 1981, Nature.

[34]  K. Arihiro,et al.  A novel cell delivery system using magnetically labeled mesenchymal stem cells and an external magnetic device for clinical cartilage repair. , 2008, Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association.

[35]  S. Dymarkowski,et al.  Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial , 2006, The Lancet.

[36]  A. Mathur,et al.  Autologous bone marrow-derived stem cells for ischemic heart failure: REGENERATE-IHD trial. , 2009, Regenerative medicine.

[37]  M. Raff.  Adult stem cell plasticity: fact or artifact? , 2003, Annual review of cell and developmental biology.

[38]  M. Neri,et al.  Efficient In Vitro Labeling of Human Neural Precursor Cells with Superparamagnetic Iron Oxide Particles: Relevance for In Vivo Cell Tracking , 2008, Stem cells.

[39]  Q. Pankhurst,et al.  Magnetic resonance imaging of mesenchymal stem cells homing to pulmonary metastases using biocompatible magnetic nanoparticles. , 2009, Cancer research.

[40]  Sylvain Martel,et al.  Magnetic microparticle steering within the constraints of an MRI system: proof of concept of a novel targeting approach , 2007, Biomedical microdevices.

[41]  Rajiv Gulati,et al.  Magnetically targeted endothelial cell localization in stented vessels. , 2006, Journal of the American College of Cardiology.

[42]  Takashi Nakagawa,et al.  Suitability of commercial colloids for magnetic hyperthermia , 2009 .